Exane Derivatives’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Exane Derivatives’s Portfolio CHNG Stock Details CHNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$184	Hold	8	–	–	﹤0.01%	680
2022 Q1	$174	Hold	8	–	–	﹤0.01%	972
2021 Q4	$171	Sell	8 -146	-95%	-$3.06K	﹤0.01%	847
2021 Q3	$3.23K	Hold	154	–	–	﹤0.01%	765
2021 Q2	$3.41K	Hold	154	–	–	﹤0.01%	793
2021 Q1	$3.4K	Hold	154	–	–	﹤0.01%	642
2020 Q4	$2.87K	Sell	154 -6,166	-98%	-$101K	﹤0.01%	596
2020 Q3	$91.7K	Buy	+6,320	New	+$80.4K	0.03%	306

Other funds holding CHNG

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Exane Derivatives's CHNG Position: Q2 2022 in Review

Exane Derivatives held its Change Healthcare Inc. Common Stock (CHNG) position steady in Q2 2022 at 8 shares worth $184. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Exane Derivatives first reported a position in CHNG in Q3 2020 and has held it in 8 quarters since. The position peaked at $91.7K in Q3 2020. 298 funds tracked by Wall St. Rank hold CHNG as of Q2 2022.

Exane Derivatives held 8 shares of Change Healthcare Inc. Common Stock worth $184 as of Q2 2022.
Exane Derivatives left its Change Healthcare Inc. Common Stock share count unchanged in Q2 2022.
Change Healthcare Inc. Common Stock made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #680 holding.
Exane Derivatives first reported a position in Change Healthcare Inc. Common Stock in Q3 2020 and has held it in 8 quarters since.
Exane Derivatives's Change Healthcare Inc. Common Stock position peaked at $91.7K in Q3 2020.
298 funds tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.